10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2013 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 24, 2014) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
| Cash flows from operating activities: | |||
| Net income | $ 5,081 | 4,345 | 3,683 |
| Depreciation and amortization | 1,286 | 1,088 | 1,060 |
| Stock-based compensation expense | 403 | 362 | 341 |
| Deferred income taxes | (189) | 28 | (328) |
| Property, plant and equipment impairments | 19 | 178 | 6 |
| Other items, net | 84 | (74) | 63 |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (38) | 348 | (557) |
| Inventories | (7) | (150) | (383) |
| Other assets | (59) | 124 | (204) |
| Accounts payable | (184) | 161 | (95) |
| Accrued income taxes | (326) | 87 | (20) |
| Legal reserve | 0 | (780) | 780 |
| Other liabilities | 221 | 165 | 773 |
| Net cash provided by operating activities | 6,291 | 5,882 | 5,119 |
| Cash flows from investing activities: | |||
| Purchases of property, plant and equipment | (693) | (689) | (567) |
| Cash paid for acquisitions, net of cash acquired | (9,434) | (2,390) | (701) |
| Purchases of marketable securities | (21,965) | (26,241) | (21,183) |
| Proceeds from sales of marketable securities | 19,123 | 17,372 | 20,871 |
| Proceeds from maturities of marketable securities | 5,090 | 1,994 | 749 |
| Change in restricted investments, net | (520) | 0 | 0 |
| Other | (70) | (36) | 45 |
| Net cash used in investing activities | (8,469) | (9,990) | (786) |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 8,054 | 4,933 | 10,387 |
| Repayment of debt | (3,371) | (123) | (2,500) |
| Net proceeds from issuance of commercial paper | 0 | 0 | 762 |
| Repayments of commercial paper | 0 | 0 | (762) |
| Repurchases of common stock | (832) | (4,607) | (8,315) |
| Dividends paid | (1,415) | (1,118) | (500) |
| Net proceeds from issuance of common stock in connection with the Company's equity award programs | 296 | 1,288 | 242 |
| Other | (6) | 46 | 12 |
| Net cash provided by (used in) financing activities | 2,726 | 419 | (674) |
| Increase (decrease) in cash and cash equivalents | 548 | (3,689) | 3,659 |
| Cash and cash equivalents at beginning of period | 3,257 | 6,946 | |
| Cash and cash equivalents at end of period | 3,805 | 3,257 | 6,946 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2013 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |